| 2865 |
Chronic Sulfur Mustard Exposure |
NM |
CRP |
NC |
Randomized double-blind clinical trial |
Placebo |
Chronic Sulfur Mustard Exposure |
=0.103 |
|
in vivo |
Homo sapiens |
|
Protein |
40 |
20 |
NM |
NM |
| 5483 |
Chronic Sulfur Mustard Exposure |
NM |
COPD Assessment Test (CAT) score |
DOWN |
Randomized double-blind clinical trial |
Placebo |
Chronic Sulfur Mustard Exposure |
=0.042 |
|
in vivo |
Homo sapiens |
|
Phenotype |
40 |
20 |
NM |
NM |
| 6103 |
Chronic Sulfur Mustard Exposure |
NM |
maximal mid-expiratory flow |
NC |
Randomized double-blind clinical trial |
Placebo |
Chronic Sulfur Mustard Exposure |
=0.063 |
|
in vivo |
Homo sapiens |
|
Phenotype |
40 |
20 |
NM |
NM |
| 6460 |
Chronic Sulfur Mustard Exposure |
NM |
forced expiratory volume in 1 second (FEV1) |
NC |
Randomized double-blind clinical trial |
Placebo |
Chronic Sulfur Mustard Exposure |
=0.12 |
|
in vivo |
Homo sapiens |
|
Phenotype |
40 |
20 |
NM |
NM |
| 6464 |
Chronic Sulfur Mustard Exposure |
NM |
FEV1/FVC ratio |
NC |
Randomized double-blind clinical trial |
Placebo |
Chronic Sulfur Mustard Exposure |
=0.254 |
|
in vivo |
Homo sapiens |
|
Phenotype |
40 |
20 |
NM |
NM |